Ohio State University Hospital Dermatology

Topics

• Nonmelanoma Skin Cancer Studies 90
• Cutaneous lymphoproliferative disorders research 73
• Contact Dermatitis and Allergies 59
• Drug-Induced Adverse Reactions 56
• Cutaneous Melanoma Detection and Management 51
• Autoimmune and Inflammatory Disorders 44
• Autoimmune Bullous Skin Diseases 42
• Dermatology and Skin Diseases 38
• Cancer and Skin Lesions 37
• Hair Growth and Disorders 30
• Psoriasis: Treatment and Pathogenesis 29
• Diversity and Career in Medicine 26

Most cited

1. Internet-Based Cognitive Behavioral Therapy for Depression: A Systematic Review and Individual Patient Data Network Meta-analysis.

   JAMA psychiatry · 2021 · 632 citations · Justine Schneider

2. Management of Immunotherapy-Related Toxicities, Version 1.2022, NCCN Clinical Practice Guidelines in Oncology.

   Journal of the National Comprehensive Cancer Network : JNCCN · 2022 · 415 citations · Benjamin Kaffenberger

3. Adjuvant Cemiplimab or Placebo in High-Risk Cutaneous Squamous-Cell Carcinoma.

   The New England journal of medicine · 2025 · 63 citations · David Carr

4. Drug-induced hypersensitivity syndrome/drug reaction with eosinophilia and systemic symptoms. Part I. Epidemiology, pathogenesis, clinicopathological features, and prognosis.

   Journal of the American Academy of Dermatology · 2024 · 71 citations · Benjamin Kaffenberger, Abraham Korman

5. Management of Adult Patients With Drug Reaction With Eosinophilia and Systemic Symptoms: A Delphi-Based International Consensus.

   JAMA dermatology · 2024 · 61 citations · Benjamin Kaffenberger

6. NCCN Guidelines® Insights: Management of Immunotherapy-Related Toxicities, Version 2.2024.